Be part of the knowledge.™

Oncology and Hematology

873

LikeLikedUnlike

16-30 of 296

Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
MinuteCE®
Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
- Eileen M. O'Reilly, MD
  Peer
- Kathryn Arbour
  Peer
0.75 program credits
RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
MinuteCE®
RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
- Kathryn Arbour
  Peer
- Eileen M. O'Reilly, MD
  Peer
0.75 program credits
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
CME/CE
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
  Peer
- Christophe Le Tourneau, MD, PhD
  Peer
0.25 credits
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
CME/CE
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
- María-Victoria Mateos, MD, PhD
  Peer
0.25 credits
Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
CME/CE
Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
- Jane Meisel, MD
  Peer
1.00 credits
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
- Marlana Orloff, MD
  Peer
- Gregory Daniels, MD, PhD
  Peer
- Jesse Keller, MD
  Peer
1.00 credits
advertisement
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
- Ryan D. Cassaday, MD
  Peer
- Daniel J. DeAngelo, MD, PhD
  Peer
1.00 credits
MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
- A.J. Gelderblom, MD, PhD
  Peer
- Michiel van de Sande, MD, PhD
  Peer
- Chelsea Cole, MD
  Peer
1.00 credits 10 episodes
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
MinuteCE®
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
- Michiel van de Sande, MD, PhD
  Peer
1.00 program credits
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
MinuteCE®
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
MinuteCE®
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
advertisement
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
- A.J. Gelderblom, MD, PhD
  Peer
- Michiel van de Sande, MD, PhD
  Peer
1.00 program credits
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
- A.J. Gelderblom, MD, PhD
  Peer
- Chelsea Cole, MD
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended